Innovating Works

MRCH

A stranger
CURELUNG: Determining epi genetic therapeutic signatures for improving lung cancer prognosis MRC HOLLAND B.V. participó en un FP7 Lung cancer (LC) is still the most lethal type of cancer worldwide. The extremely poor prognosis for LC patients is partly due to the lack o...
financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.